secwatch.observer — SEC 8-K summary
======================================

Issuer:     Day One Biopharmaceuticals, Inc. (—)
CIK:        0001845337
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001193125-23-173808
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Day One shareholders approve officer exculpation charter amendment; elect two directors
--------------------------------------------------------------------------------

- Stockholders approved Certificate of Amendment to limit officer liability under Delaware DGCL, filed June 22, 2023.
- Scott Garland and John Josey elected as Class II directors for three-year terms expiring 2026.
- Garland received 63,229,607 votes for; Josey received 52,093,255 votes for.
- Ratification of Ernst & Young as independent auditor for FY2023: 66,370,613 votes for, 12,503 against.
- Amendment and director elections effective at the 2023 Annual Meeting held June 22, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845337/000119312523173808/0001193125-23-173808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845337/000119312523173808/d508417d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-173808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer